Immediate Impact
37 standout
Citing Papers
Prostate Cancer
2025 Standout
Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy
2025 Standout
Works of Edward J. Drea being referenced
Real-world outcomes in patients with metastatic castration-resistant prostate cancer receiving second-line chemotherapy versus an alternative androgen receptor-targeted agent (ARTA) following early progression on a first-line ARTA in a US community oncology setting
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Edward J. Drea | 82 | 74 | 46 | 45 | 256 | |
| William B. Hauser | 58 | 103 | 104 | 26 | 297 | |
| Rebecca Ruth Gould | 83 | 96 | 9 | 84 | 232 | |
| John M. Merriman | 36 | 76 | 19 | 27 | 231 | |
| Liam Kennedy | 47 | 134 | 16 | 37 | 285 | |
| William C. Harris | 34 | 177 | 30 | 33 | 292 | |
| Peter Hanns Reill | 36 | 51 | 9 | 36 | 300 | |
| William H. Frederick | 82 | 197 | 33 | 32 | 284 | |
| David E. Bernstein | 46 | 61 | 4 | 46 | 217 | |
| Caroline Osborne | 14 | 91 | 10 | 34 | 330 | |
| Christopher R. Boyer | 41 | 26 | 16 | 20 | 202 |
All Works
Loading papers...